Mon. May 25th, 2026
Spread the love

NBA Africa Triple-Double Accelerator aims to support the next wave of early-stage African startup businesses transforming the sports and creative sectors.

The accelerator scouts bold founders across the continent, equipping them with AI-first capacity building, global mentorship, world-class coaching, and direct access to investors, partners, and fans.

Theme:

The Triple-Double Accelerator is seeking tech-enabled startups whose products and or services align with the following categories:

  • Sports & Innovation
  • Creative Startups

Eligibility Criteria

  • Are headquartered in Africa
  • Are less than 2 years old
  • Are building in the sports or creative industries
  • Have a tech-enabled solution with clear market value
  • Have a proof-of-concept prototype with potential for profit, inclusivity, and scale
  • Have two co-founders committed full-time (40+ hrs/week)
  • Are preferably registered as a company

Benefits

  • The shortlisted startups will enroll in a 10-week mentorship program where they will be paired with mentors comprised of NBA Africa, ServiceNow, ALX leadership, and other corporate stakeholders who will provide guidance to the companies with a focus on product development, business growth and go-to-market strategy.
  • Top 5 winners will stand to win up to $50,000 in cash and value-in-kind benefits each
  • Business coaching and advisory from global experts
  • Brand visibility across the NBA and ALX ecosystem
  • Masterclasses on AI, product, sales, fundraising & more
  • Pitch refinement with mock rounds and expert guidance
  • Networking opportunities with alumni, investors & clients
  • Personalized roadmap to help you hit product, revenue, or investor goals
  • In-person event in a major African city
  • Spotlight and PR at the Demo Day

Application Procedure:

  • What’s your startup’s story? Who do you serve, what problem do you solve, and what makes your solution different?
  • What traction have you achieved? Share key metrics, milestones, and customer growth.
  • Who’s behind the business? Introduce your co-founders and team dynamics.
  • How does your business make money? Walk us through your revenue model.
  • What impact are you creating? Tell us how your work will create jobs on the continent.
  • Have something to show? Upload your pitch deck or product demo (if available).

Timeline:

STEP 1: Written Application

Application Deadline 29 August 2025

Founders must complete the online application (roughly 60 mins to complete).

Applications will be reviewed on a rolling basis, so we encourage applying as early as possible.

STEP 2: One-way Video Interview

Deadline 12 September 2025

Selected startups will be invited to participate in a one-way video interview.

Video submissions should be no longer than 3 minutes.

STEP 3: Selection Process

Deadline: 30 September 2025

Judges will evaluate each submission and select the top startups to participate in the program

STEP 4: Program

October – December 2025

The 10-week accelerator program includes masterclasses, mentorship, and pitch practice in preparation for Demo Day in December

The required time commitment will be 4-6 hours per week, not including Demo Day

STEP 5: Demo Day

December 2025

The final participating startups will get the opportunity to pitch to global industry leaders in a major African city for a chance to win prizes.

Note: All dates are subject to change and are subject to the Terms & Conditions of the program.

METHOD OF APPLICATION

Interested and Qualified should Go Click Link Below to Apply.

CLICK HERE TO APPLY

The post Apply Now : NBA Africa’s Triple Double Accelerator Program 2025 For African Startups ($50,000 In Cash Prize) appeared first on Advert By Dotifi .Com Domains for almajiri.com.ng | Best African Hausa Music Blog, Entertainment ,News and Gossips .

By 9jabook

You missed

From Tramadol to Canadian to Exol-5 The New Drug Destroying Nigerian Youths An Investigative Article .From Tramadol to Canadian to Exol-5: The New Drug Destroying Nigerian Youths An Investigative Report on the Shifting Landscape of Substance Abuse in Nigeria Nigeria faces a severe and evolving drug crisis, particularly among its youth. What began with the widespread abuse of Tramadol has progressed through mixtures like “Canadian” to newer pharmaceutical diversions such as Exol-5. This shift reflects deeper issues: easy access to prescription drugs, weak regulation, socioeconomic pressures, and aggressive street-level marketing. NDLEA operations and health studies reveal a public health emergency that threatens an entire generation. Phase 1: The Tramadol Epidemic (2010s–Early 2020s) Tramadol, a synthetic opioid prescribed for moderate to severe pain, became Nigeria’s most notorious street drug. Cheap, potent, and widely smuggled (often from India and other Asian countries), it offered users energy, euphoria, and pain relief — appealing to commercial drivers, laborers, students, and young men seeking confidence or stamina. Scale of the Problem: Millions of tablets seized annually by NDLEA. High prevalence among young males aged 15–35. Linked to increased crime, sexual violence, organ damage (kidney failure, seizures), and mental health breakdowns. Contributed to broader opioid misuse alongside codeine cough syrups. Government responses included tighter import controls and public awareness campaigns, but these only displaced demand to other substances rather than eliminating it. Phase 2: The Rise of “Canadian” (Mid-2020s) “Canadian” or “Canadian Loud” emerged as a popular code for high-grade cannabis (often indica-dominant strains) or cannabis mixed with other synthetics. It gained traction as users sought alternatives or combinations to Tramadol’s effects. This phase marked a move toward imported or locally cultivated premium weed, sometimes laced with stronger chemicals. Youths in urban centers like Lagos, Kano, Jos, and Onitsha embraced it for its perceived “cleaner” high compared to opioids. However, it fueled polydrug use — combining cannabis with opioids, sedatives, or alcohol — amplifying health risks. Phase 3: Exol-5 – The Current Threat (2024–2026) Exol-5 (Benzhexol Hydrochloride / Trihexyphenidyl 5mg), originally a prescription medication for Parkinson’s disease and drug-induced movement disorders, has become the latest pharmaceutical being heavily abused. Why Exol-5? Euphoric Effects: Users report intense euphoria, hallucinations, and a sense of detachment — making it attractive as a cheap “upper” or escape. Accessibility: Sold over-the-counter or on the black market despite being a controlled prescription drug. NDLEA has seized millions of pills in single operations (e.g., 3.1 million pills in Kano in late 2024, and over 5.6 million combined with Tramadol in other busts). Street Names: Exol, Artane, Benzhexol, “Farin Mallam” (in Northern Nigeria). Demographics: Prevalent among youths, laborers, and even psychiatric patients who divert prescriptions. Studies show abuse rates as high as 25% among certain outpatient groups. Health Consequences: Anticholinergic toxicity: Confusion, dry mouth, blurred vision, urinary retention, constipation, and in high doses — delirium, psychosis, seizures, and heart issues. Long-term: Cognitive impairment, addiction, exacerbated mental health disorders. Often mixed with Tramadol, codeine, or cannabis, creating dangerous synergies. In cities like Jos, Exol-5 sits alongside diazepam, Rohypnol, and Tramadol on street markets, easily available to teenagers and young adults. Why This Evolution Continues Supply-Side Failures: Porous borders, corrupt officials, and overproduction of pharmaceuticals enable diversion. Demand Drivers: Unemployment, poverty, peer pressure, trauma, and the pursuit of performance enhancement (e.g., for “hustle” culture). Weak Regulation: Many pharmacies sell restricted drugs without prescriptions. Online and street vendors fill gaps. Displacement Effect: Cracking down on one substance (Tramadol/codeine) pushes users and dealers toward the next available option. NDLEA reports ongoing large seizures, but the problem persists due to high profitability and low risk for mid-level distributors. Broader Impacts on Nigerian Youths Education: Increased dropout rates and poor academic performance. Mental Health: Rising cases of psychosis and depression. Economy: Lost productivity among the working-age population. Crime and Violence: Drug-fueled robberies, cultism, and family breakdowns. Public Health System Strain: Overburdened hospitals treating overdoses and chronic complications. Young people aged 15–39 remain the hardest hit, with national surveys showing drug use prevalence significantly above global averages. What Must Be Done Stronger Enforcement: Consistent prosecution of corrupt enablers and large-scale traffickers. Regulation: Crackdown on rogue pharmacies and better tracking of prescription drugs. Prevention & Rehabilitation: School programs, community outreach, and expanded treatment centers (currently woefully inadequate). Economic Alternatives: Address root causes like youth unemployment. Public Awareness: Honest campaigns highlighting real dangers of “Exol-5” and similar drugs. Conclusion From Tramadol’s opioid grip to “Canadian” cannabis culture and now Exol-5’s anticholinergic highs, Nigeria’s drug crisis is mutating faster than responses can contain it. Exol-5 represents the dangerous new frontier — a legitimate medicine turned youth destroyer due to misuse and greed. Without urgent, multi-layered intervention — combining supply disruption, demand reduction, and socioeconomic support — an entire generation risks being lost to addiction. The time for half-measures is over. Nigeria’s future depends on winning this fight.